Quality of Life of Hypertensive Patients Undergoing Chronic Disease Management Program during the COVID-19 Pandemic

Abstract

Abstract The COVID-19 pandemic has restricted some common activities for hypertensive patients undergoing the Chronic Disease Management Program at primary health care, decreasing the quality of life. This study aimed to measure the quality of life of hypertensive patients undergoing the Chronic Disease Management Program at primary health care of Manado City, North Sulawesi Province, Indonesia, during the COVID-19 pandemic. Also to determine factors influencing hypertension such as sex, age, education, employment status, monthly income and duration of hypertension. This cross-sectional study was carried out on 150 hypertensive patients randomly sampled at primary health care from June to September 2021. The data were analyzed using the Mann-Whitney test. The utility value and the visual analog scale of hypertensive patients with and without complications were 0.808±0.13 and 80.2±8.16 and 0.761±0.17 and 75.1±7.56, respectively. The quality of life of hypertensive patients without complication is better than that of hypertensive patients with complication. Keywords: Chronic Disease Management Program, COVID-19, hypertension, noncommunicable disease, quality of life